Filing Details

Accession Number:
0001562180-21-001045
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-10 16:26:24
Reporting Period:
2021-02-08
Accepted Time:
2021-02-10 16:26:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590877 Regenxbio Inc. RGNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1521123 J. Patrick Christmas C/o Regenxbio Inc.
9600 Blackwell Road, Suite 210
Rockville MD 20850
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-08 1,300 $12.10 17,672 No 4 M Direct
Common Stock Disposition 2021-02-08 1,300 $49.11 16,372 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-02-08 1,300 $0.00 1,300 $12.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,131 2026-08-17 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $49.00 to $49.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.